Replimune Group Inc (NASDAQ:REPL)

23.63
Delayed Data
As of Aug 07
 +2.25 / +10.52%
Today’s Change
8.58
Today|||52-Week Range
26.22
+64.67%
Year-to-Date
No recent news for Replimune Group Inc.

Today’s Trading

Previous close21.38
Today’s open21.59
Day’s range21.59 - 24.07
Volume8,391
Average volume (3 months)181,492
Market cap$953.6M
Data as of 3:59pm ET, 08/07/2020

Growth & Valuation

Earnings growth (last year)-15.57%
Earnings growth (this year)-15.96%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.70

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+0.14+1.12%
RTRXRetrophin Inc+0.09+0.47%
VBIVVBI Vaccines Inc+0.04+0.95%
TLRYTilray Inc-0.29-3.74%
Data as of 3:59pm ET, 08/07/2020

Financials

Next reporting dateNovember 9, 2020
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$0.00
Annual profit (last year)-$52.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Woburn, Massachusetts

Forecasts